Nova Cannabis Inc

Healthcare CA NOVC

1.75CAD
-(-%)

Last update at 2024-10-22T20:00:00Z

Day Range

1.741.75
LowHigh

52 Week Range

0.401.00
LowHigh

Fundamentals

  • Previous Close 1.75
  • Market Cap53.20M
  • Volume5413
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA11.14M
  • Revenue TTM253.32M
  • Revenue Per Share TTM4.43
  • Gross Profit TTM 24.89M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.20500M -20.61400M -9.27300M -5.78700M -16.08644M
Minority interest - - - - -
Net income -11.20500M -20.61400M -9.27300M -2.70200M -16.08644M
Selling general administrative 34.97M 27.86M 3.91M 3.91M 14.72M
Selling and marketing expenses - - - - -
Gross profit 43.85M 24.89M 6.38M 2.70M -
Reconciled depreciation 10.90M 10.05M 4.26M 1.70M -
Ebit -3.42700M -11.78800M 0.42M -5.18600M -8.50920M
Ebitda 3.72M -7.32000M -4.10400M -3.41200M -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -7.54200M -13.19600M -6.32200M -4.78600M -16.24946M
Other operating expenses - - - - -
Interest expense 3.98M 3.07M 0.91M 0.68M 0.00000M
Tax provision - - 0.00000M -3.08500M -
Interest income 3.66M 2.62M 0.03M 0.19M 0.16M
Net interest income -3.98300M -3.21600M -0.87200M -0.48600M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 226.42M 134.36M 21.02M 8.54M 0.00000M
Total operating expenses 230.07M 147.56M 27.34M 13.33M -
Cost of revenue 182.57M 109.48M 14.64M 5.84M -
Total other income expense net -3.56800M -4.20200M -2.07900M -0.51500M -
Discontinued operations - - - - -
Net income from continuing ops -11.20500M -20.61400M -9.27300M -2.70200M -
Net income applicable to common shares -11.20500M -20.61400M -2.07300M -8.73900M -11.45040M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 113.15M 118.70M 35.37M 44.00M 28.14M
Intangible assets - 0.00000M 14.56M 15.64M 4.25M
Earning assets - - - - -
Other current assets - 0.17M 0.55M 1.75M 0.20M
Total liab 65.33M 59.93M 13.41M 14.08M 2.49M
Total stockholder equity 47.82M 58.77M 21.96M 29.93M 25.64M
Deferred long term liab - - - - -
Other current liab 0.00200M 0.08M 1.13M 1.64M 0.46M
Common stock 97.73M 97.62M 37.27M 13.50M 13.50M
Capital stock 97.73M 97.62M 51.35M 50.67M -
Retained earnings -52.03100M -40.82600M -20.21200M -18.13900M -9.54200M
Other liab - - - - 1.93M
Good will 19.27M 19.27M 0.00000M - -
Other assets 0.96M 0.98M 0.37M 0.33M 0.39M
Cash 5.03M 10.53M 1.75M 6.41M 14.69M
Cash and equivalents - - - - -
Total current liabilities 19.89M 13.41M 7.85M 29.09M 9.93M
Current deferred revenue - - - - -
Net debt 3.64M - - - -
Short term debt 8.68M 0.00000M 0.02M 0.00000M 0.00000M
Short long term debt 8.68M - - - -
Short long term debt total - - 31.92M 11.12M -
Other stockholder equity - - - - -
Property plant equipment 74.19M 77.36M 49.54M 43.27M 8.55M
Total current assets 18.73M 21.09M 6.50M 7.47M 6.89M
Long term investments - - - - -
Net tangible assets 28.55M 39.50M 16.63M -6.13900M 3.96M
Short term investments - - - - -
Net receivables 1.32M 1.16M 0.27M 0.33M 0.53M
Long term debt - - 0.20M - -
Inventory 11.67M 8.73M 3.39M 4.12M 2.95M
Accounts payable 1.96M 3.43M 0.66M 5.92M 3.88M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 94.42M 97.61M 31.89M 35.19M -
Capital lease obligations 50.56M 51.97M 11.65M 12.07M -
Long term debt total 45.44M 46.52M 31.92M 11.12M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -8.40800M -12.37400M -1.85800M -8.58400M -
Change to liabilities 0.56M 0.69M 7.30M -2.46800M 6.13M
Total cashflows from investing activities -8.40800M -12.37400M -8.54900M -5.68200M -10.53480M
Net borrowings 2.96M -5.67400M -3.53300M -2.22500M -2.22500M
Total cash from financing activities 2.98M 31.44M -3.53300M -2.22500M -2.22500M
Change to operating activities -0.01300M 2.08M -0.77300M 12.94M 18.84M
Net income -11.20500M -20.61400M -2.07300M -8.73900M -11.45040M
Change in cash -5.49400M 9.09M -0.74800M 0.00200M 2.62M
Begin period cash flow 10.53M 1.75M 6.41M 19.62M -
End period cash flow 5.03M 10.53M 1.75M 6.41M 19.62M
Total cash from operating activities -0.06500M -9.97800M 11.33M 7.91M 13.15M
Issuance of capital stock 0.02M 37.12M - - -
Depreciation 10.90M 8.55M 5.31M 3.57M 0.17M
Other cashflows from investing activities 0.00000M -1.08500M -0.82300M -0.82300M -0.82300M
Dividends paid - - - - -
Change to inventory -2.93500M -5.29100M 0.90M -1.09500M -2.83920M
Change to account receivables -0.16400M -0.75100M 0.05M 0.20M -0.63120M
Sale purchase of stock 0.02M 37.12M 0.00000M 0.00000M 30.84M
Other cashflows from financing activities - - -0.15400M -0.36800M -2.04027M
Change to netincome 2.79M 5.36M 0.62M 3.50M 2.94M
Capital expenditures 8.41M 11.70M 7.76M 4.27M 10.53M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.55600M -3.27400M 0.50M -1.05900M -0.74704M
Stock based compensation 0.06M - 0.63M 0.87M -
Other non cash items -0.19400M 1.23M 0.91M 0.68M -
Free cash flow -8.47300M -21.67300M -0.89500M -3.16400M -

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NOVC
Nova Cannabis Inc
- -% 1.75 - 4.89 0.21 1.06 0.42 7.69

Reports Covered

Stock Research & News

Profile

Nova Cannabis Inc. engages in the operation of retail cannabis stores with a focus on the recreational-use cannabis market in Canada. Nova Cannabis Inc. is headquartered in Edmonton, Canada. Nova Cannabis Inc. is a subsidiary of Alcanna Inc.

Nova Cannabis Inc

17220 Stony Plain Road, Edmonton, AB, Canada, T5S1K6

Key Executives

Name Title Year Born
Ms. Marcie Catherine Kiziak Pres, CEO & Director 1980
Mr. Grant Sanderson VP of Operations NA
Mr. Cameron R. Sebastian CA CFO & Corp. Sec. 1963

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.